id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-0002-0017,FDA,FDA-2022-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address,Rule,Final Rule,2022-12-14T05:00:00Z,2022,12,2022-12-14T05:00:00Z,,2022-12-14T15:03:27Z,2022-24106,0,0,0900006485536264
FDA-2022-N-0002-0018,FDA,FDA-2022-N-0002,"FOI Summary for cN 141-556, approved June 16, 2022",Supporting & Related Material,Background Material,2022-12-14T05:00:00Z,2022,12,,,2022-12-14T17:15:26Z,,0,0,090000648553667b
FDA-2022-N-0002-0019,FDA,FDA-2022-N-0002,"FOI Summary for sN 141-137, approved April 28, 2022",Supporting & Related Material,Background Material,2022-12-14T05:00:00Z,2022,12,,,2022-12-14T17:16:06Z,,0,0,090000648553667c
FDA-2022-N-0002-0004,FDA,FDA-2022-N-0002,FOI Summary oA 200-707 approved January 25 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:15:18Z,,0,0,0900006485381e58
FDA-2022-N-0002-0010,FDA,FDA-2022-N-0002,FOI Summary oA 200-716 approved January 28 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:16:19Z,,0,0,0900006485381e5e
FDA-2022-N-0002-0008,FDA,FDA-2022-N-0002,FOI Summary oA 200-723 approved March 23 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:16:01Z,,0,0,0900006485381e5c
FDA-2022-N-0002-0016,FDA,FDA-2022-N-0002,FOI Summary sN 131-675 approved January 10 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:17:36Z,,0,0,0900006485381e75
FDA-2022-N-0002-0003,FDA,FDA-2022-N-0002,FOI Summary oA 200-688 approved March 28 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:15:10Z,,0,0,0900006485381696
FDA-2022-N-0002-0005,FDA,FDA-2022-N-0002,FOI Summary oA 200-715 approved February 9 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:15:31Z,,0,0,0900006485381e59
FDA-2022-N-0002-0001,FDA,FDA-2022-N-0002,New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Name and Address,Rule,Final Rule,2022-09-29T04:00:00Z,2022,9,2022-09-29T04:00:00Z,,2022-09-29T13:00:29Z,2022-20836,0,0,090000648538095f
FDA-2022-N-0002-0006,FDA,FDA-2022-N-0002,FOI Summary oA 200-721 approved March 28 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:15:44Z,,0,0,0900006485381e5a
FDA-2022-N-0002-0007,FDA,FDA-2022-N-0002,FOI Summary oA 200-722 approved March 28 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:15:52Z,,0,0,0900006485381e5b
FDA-2022-N-0002-0012,FDA,FDA-2022-N-0002,FOI Summary oA 200-718 approved February 7 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:16:46Z,,0,0,0900006485381e60
FDA-2022-N-0002-0011,FDA,FDA-2022-N-0002,FOI Summary oA 200-717 approved February 7 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:16:33Z,,0,0,0900006485381e5f
FDA-2022-N-0002-0009,FDA,FDA-2022-N-0002,FOI Summary oN 141-546 approved January 13 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:16:11Z,,0,0,0900006485381e5d
FDA-2022-N-0002-0014,FDA,FDA-2022-N-0002,FOI Summary oN 141-547 approved January 20 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:17:11Z,,0,0,0900006485381e73
FDA-2022-N-0002-0002,FDA,FDA-2022-N-0002,FOI Summary oA 200-665 approved February 7 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:14:56Z,,0,0,0900006485381695
FDA-2022-N-0002-0015,FDA,FDA-2022-N-0002,FOI Summary oN 141-551 approved March 30 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:17:23Z,,0,0,0900006485381e74
FDA-2022-N-0002-0013,FDA,FDA-2022-N-0002,FOI Summary oA 200-720 approved March 11 2022,Supporting & Related Material,Background Material,2022-09-29T04:00:00Z,2022,9,,,2022-09-29T20:17:00Z,,0,0,0900006485381e61